STIM1 and melanoma: For example, STIM1-dependent signaling in non-tumor cells has been proposed to affect the outcomes of melanoma patients 13-15, therefore, the biological roles and functional impacts of STIM1 status in non-malignant cell types within the tumor microenvironment should be examined alongside ectopic STIM1 expression within malignant cells.